Back to OVID
GOLDMAN SACHS GROUP INC → OVID
GOLDMAN SACHS GROUP INC OVID Position History
Ovid Therapeutics Inc. • Healthcare
Quarters held
12
Latest value
$850K
Q3 2026
Peak value
$850K
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $27K |
| Q1 2025 | $6K |
| Q2 2025 | $88K |
| Q2 2025 | $5K |
| Q3 2025 | $37K |
| Q4 2025 | $278K |
| Q4 2025 | $278K |
| Q1 2026 | $339K |
| Q2 2026 | $308K |
| Q2 2026 | $587K |
| Q3 2026 | $680K |
| Q3 2026 | $850K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $850K | 341.4K | — | — |
| Q3 2026 | $680K | 273.0K | — | — |
| Q2 2026 | $587K | 218.3K | — | — |
| Q2 2026 | $308K | 114.4K | — | — |
| Q1 2026 | $339K | 152.8K | — | — |
| Q4 2025 | $278K | 170.5K | — | — |
| Q4 2025 | $278K | 170.5K | — | — |
| Q3 2025 | $37K | 28.5K | — | — |
| Q2 2025 | $5K | 15.7K | — | — |
| Q2 2025 | $88K | 268.2K | — | — |
| Q1 2025 | $6K | 18.1K | — | — |
| Q1 2025 | $27K | 86.3K | — | — |